Production of Antibodies in Plants: Approaches and Perspectives

  • K. Ko
  • R. Brodzik
  • Z. Steplewski
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 332)

Advances in molecular biology, immunology, and plant biotechnology have changed the paradigm of plant as a food source to so-called plant bioreactor to produce valuable recombinant proteins. These include therapeutic or diagnostic monoclonal antibodies, vaccines, and other biopharmaceutical proteins. The plant as a bioreactor for the production of therapeutic proteins has several advantages, which include the lack of animal pathogenic contaminants, low cost of production, and ease of agricultural scale-up compared to other currently available systems. Thus, plants are considered to be a potential alternative to compete with other systems such as bacteria, yeast, or insect and mammalian cell culture. Plant production systems, particularly therapeutic antibodies, are very attractive to pharmaceutical companies to produce the antibodies in demand. Currently, we have successfully developed a plant system for production of anti-rabies monoclonal antibody and anti-colorectal cancer monoclonal antibody. The effective plant production system for recombinant antibodies requires the appropriate plant expression machinery with optimal combination of transgene expression regulatory elements, control of posttranslational protein processing, and efficient purification methods for product recovery. However, there are several limitations that have to be resolved to establish the efficient plant system for antibody production. Here, we discuss the approaches and perspectives in plant systems to produce monoclonal antibody.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH, Jordi W, Lommen A, Faye L, Lerouge P, Bosch D (2001) Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 98:2899–2904PubMedCrossRefGoogle Scholar
  2. Baum TJ, Hiatt A, Parrott WA, Pratt LH, Hussey RS (1996) Expression in tobacco of a functional monoclonal antibody specific to stylet secretions of the root-knot nematode. Molecular Plant-Microbe Interaction 9:382–387Google Scholar
  3. Boothe JG, Saponja JA, Parmenter DL (1997) Molecular farming in plants: oilseeds as vehicles for the production of pharmaceutical proteins. Drug Develop Res 42:172–181CrossRefGoogle Scholar
  4. Borisjuk N V, Borisjuk LG, Logendra S, Petersen F, Gleba Y, Raskin I (1999) Production of recombinant proteins in plant root exudates. Nat Biotechnol 17:466–469PubMedCrossRefGoogle Scholar
  5. Brockmann EC, Cooper M, Stromsten N, Vehniainen M, Saviranta P (2005) Selecting for antibody scFV fragments with improved stability using phage display with denaturation under reducing conditions. J Immunol Methods 296:159–170PubMedCrossRefGoogle Scholar
  6. Burton DR (2002) Antibodies, viruses and vaccines. Nat Rev Immunol 2:706–713PubMedCrossRefGoogle Scholar
  7. Burton DR, Barbas CFr (1994) Human antibodies from combinatorial libraries. Adv Immunol 57:191–280PubMedCrossRefGoogle Scholar
  8. Cabanes-Macheteau M, Fitchette-Laine AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK, Lerouge P, Faye L (1999) N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 9:365–372PubMedCrossRefGoogle Scholar
  9. Carter P (2001) Bispecific human IgG by design. J Immunol Methods 248:7–15PubMedCrossRefGoogle Scholar
  10. Casadevall A, Dadachova E, Pirofski L (2004) Passive antibody therapy for infectious diseases. Nat Microbiol 2:695–702CrossRefGoogle Scholar
  11. Chadd HE, Chamow SM (2001) Therapeutic antibody expression technology. Curr Opin Biotechnol 12:188–194PubMedCrossRefGoogle Scholar
  12. Chargelegue D, Vine ND, van Dolleweerd CJ, Drake PM, Ma JK (2000) A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice. Transgenic Res 9:187–194PubMedCrossRefGoogle Scholar
  13. Colby DW, Garg P, Holden T, Chao G, Webster JM, Messer A, Ingram VM, Wittrup KD (2004) Development of a human light chain variable domain (VL) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display. J Mol Biol 342:901–912PubMedCrossRefGoogle Scholar
  14. Coloma MJ, Trinh RK, Martinez AR, Morrison SL (1999) Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1-->6) dextran antibody. J Immunol 162:2162–2170PubMedGoogle Scholar
  15. Conrad U, Fiedler U (1998) Compartment-specific accumulation of recombinant immunoglobu-lins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol Biol 38:101–109PubMedCrossRefGoogle Scholar
  16. D'Aoust M-A, Lerouge P, Busse U, Bilodeau P, Trepanier S, Gomord V, Faye L, Vezina L-P (2004) Efficient and reliable production of pharmaceutical in alfalfa. In: Fischer R, Schillberg S (eds) Molecular Farming: Plant-made Pharmaceuticals and Technical Protein. Wiley, Weinheim, pp. 1–11Google Scholar
  17. Daniell H (2002a) Medical molecular pharming: expression of antibodies, biopharmaceuticals and edible vaccines via the chloroplast genome. In: V. I.K (ed) Plant Biotechnology 2002 and Beyond, Plant Biotechnology 2002 and Beyond. Kluwer Academic Publishers, Orlando, pp. 371–376Google Scholar
  18. Drake PMW, Chargelegue D, Vine ND, Van Dolleweerd CJ, Obregon P, Ma JK-C (2002) Transgenic plants expressing antibodies: a model for phytoremediation. FASEB J 16:1855–1860PubMedCrossRefGoogle Scholar
  19. Duering K (1988) Wundinduzierbare und Sekretion von T4 Lysozym und monoklonalen Antikorpern in Nicotiana tabcum. PhD thesis, Universität Koln, FRGGoogle Scholar
  20. Fischer R, Schumann D, Zimmermann S, Drossard J, Sack M, Schillberg S (1999) Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants. Eur J Biochem 262:810–816PubMedCrossRefGoogle Scholar
  21. Fitchette-Laine AC, Gomord V, Chekkafi A, Faye L (1994) Distribution of xylosylation and fucosylation in the plant Golgi apparatus. Plant J 5:673–682CrossRefGoogle Scholar
  22. Gleba Y, Klimyuk V, Marillonnnet S (2005) Magnifection-a new platform for expressing recom-binant vaccines in plants. Vaccine 23:2042–2048PubMedCrossRefGoogle Scholar
  23. Gomord V, Sourrouille C, Fitchette A-C, Bardor M, Pagny S, Lerouge P, Faye L (2004) Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J 2:83–100PubMedCrossRefGoogle Scholar
  24. Harris M (2004) Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 5:292–302PubMedCrossRefGoogle Scholar
  25. Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40:717–721PubMedGoogle Scholar
  26. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1986) CO17-1A and related monoclonal antibodies: Their production and characterization. Hybridoma 5:3–S10PubMedGoogle Scholar
  27. Hiatt A, Caffertey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76–78PubMedCrossRefGoogle Scholar
  28. Houghton AN, Scheinberg DA (2000) Monoclonal antibody therapies—a ‘constant’ threat to cancer. Nat Med 6:373–374PubMedCrossRefGoogle Scholar
  29. Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H, Chapman G, Legutki B, Baillie L, Yusibov V (2005) Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 23:2082–2086PubMedCrossRefGoogle Scholar
  30. Jobling SA, Jarman C, Teh MM, Holmberg N, Blake C, Verhoeyen ME (2003) Immunomodulation of enzyme function in plants by single-domain antibody fragments. Nat Biotechnol 21:77–80PubMedCrossRefGoogle Scholar
  31. Juwied M, Neumann R, Paik C, MJ, P-B, Sato J, van Osdol W, Weinstein JN (1992) Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 52:5144–5153Google Scholar
  32. Kathuria S, Sriraman R, Nath R, Sack M, Pal R, Artsaenko O, Talwar GP, Fischer R, Finnern R (2002) Efficacy of plant-produced recombinant antibodies against HCG. Hum Reprod 17:2054–2061PubMedCrossRefGoogle Scholar
  33. Ko K, Koprowski, H (2005) Plant biopharming of monoclonal antibodies. Virus Res 111:93–100PubMedCrossRefGoogle Scholar
  34. Ko K, Steplewski Z, Glogowska M, Koprowski H (2005) Inhibition of tumor growth by plant-derived mAb. Proc Natl Acad Sci USA 102:7026–7030PubMedCrossRefGoogle Scholar
  35. Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci USA 100:8013–8018PubMedCrossRefGoogle Scholar
  36. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497PubMedCrossRefGoogle Scholar
  37. Koprivova A, Stemmer C, Altmann F, Hoffmann A, Kopriva S, Gorr G, Reski R, Decker EL (2004) Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2:517–523PubMedCrossRefGoogle Scholar
  38. Koprowski H, Black J (1952) Studies on chick-embryo-adapted rabies virus. J Immunol 72:79–84Google Scholar
  39. Koprowski H, Yusibov V (2001) The green revolution: plants as heterologous expression vectors. Vaccine 19:2735–2741PubMedCrossRefGoogle Scholar
  40. Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C (1998) Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group. Bull World Health Organ 76:491–495PubMedGoogle Scholar
  41. Le Gall F, Bove J-M, Garnier M (1998) Engineering of a single-chain variable-fragment (scFv) antibody specific for the stolbur phytoplasma (mollicute) and its expression in Escherichia coli and tobacco plants. Appl Environ Microbiol 64:4566–4572Google Scholar
  42. Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805PubMedCrossRefGoogle Scholar
  43. Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T (1995) Generation and assembly of secretory antibodies in plants. Science 268:716–719PubMedCrossRefGoogle Scholar
  44. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237–243PubMedCrossRefGoogle Scholar
  45. Marillonnnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 23:718–723CrossRefGoogle Scholar
  46. Matusuuchi L, Sharon J, Morrison SL (1981) An analysis of heavy chain glycospeptides of hybri-doma antibodies: correlation between antibody specificity and sialic acid content. J Immunol 127:2188–2190Google Scholar
  47. Mayfield SP, Franklin SE, Lerner RA (2003) Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA 100:438–442PubMedCrossRefGoogle Scholar
  48. McCall AM, Shahied L, Amoroso AR, Horak EM, Simmons HH, Nielson U, Adams GP, Schier R, Marks JD, Wiener LM (2001) Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity. J Immunol 166:112–117Google Scholar
  49. McCormick AA, Kumagai MH, Hanley K, Turpen TH, Hakim I, Grill LK, Tuse D, Levy S, Levy R (1999) Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco. Proc Natl Acad Sci USA 96:703–708PubMedCrossRefGoogle Scholar
  50. Miroshinichenko S, Tripp J, Nieden U, Neumann D, Conrad U, Manteuffel R (2005) Immunomodulation of function of small heat shock proteins prevents their assembly into heat stress granules and results in cell death at sublethal temperatures. Plant J 41:269–281CrossRefGoogle Scholar
  51. Montefiori DC (2005) Neutralizing antibodies take a swipe at HIV in vivo. Nat Med 11:593–594PubMedCrossRefGoogle Scholar
  52. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GSJ, Casadevall A (2003) Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112:1164–1175PubMedGoogle Scholar
  53. Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, Sheridan R, Blake R, Smith LA, Marks JD (2002) Potent neutralization of botulinum neurotoxin by recom-binant oligoclonal antibody. Proc Natl Acad Sci USA 99:11346–11350PubMedCrossRefGoogle Scholar
  54. Nuttall J, Ma JK-C, Frigerio L (2005) A functional antibody lacking N-linked glycans is efficiently folded, assembled and secreted by tobacco mesophyll protoplasts. Plant Biotechnol J 3:497–504PubMedCrossRefGoogle Scholar
  55. Nuttall J, Vine ND, Hadlington JL, Drake P, Frigerio L, Ma JK-C (2002) ER-resident chaperone interactions with recombinant antibodies in transgenic plants. FEBS 269:6042–6051Google Scholar
  56. Peeters K, De Wilde C, Depicker A (2001) Highly efficient targeting and accumulation of a F(ab) fragment within the secretory pathway and apoplast of Arabidopsis thaliana. Eur J Biochem 268:4251–4260PubMedCrossRefGoogle Scholar
  57. Prosniak M, Faber M, Hanlon CA, Rupprecht C, Hooper DC, Dietzschold B (2003) Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for post-exposure prophylaxis of rabies. J Infect Dis 187:30386–30389Google Scholar
  58. Schier R, Balint RF, McCall A, Apell G, Larrick JW, Marks JD (1996) Identification of functional and structural amino-acid residues by parsimonious mutagenesis. Gene 169:147–155PubMedCrossRefGoogle Scholar
  59. Schiermeyer A, Dorfmuller S, Schinkel H (2004) Production of pharmaceutical proteins in plants and plant cell suspension cultures.Google Scholar
  60. Schillberg S, Zimmermann S, Zhan M-Y, Fischer R (2001) Antibody-based resistance to plant pathogens. Transgenic Res 10:1–12PubMedCrossRefGoogle Scholar
  61. Schlesinger JJ, Foltzer M, Chapman S (1993) The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132–141PubMedCrossRefGoogle Scholar
  62. Schumacher CL, Ertl HC, Koprowski H, Dietzschold B (1992) Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine 10:754–760PubMedCrossRefGoogle Scholar
  63. Senveno M, Bardor M, Paccalet T (2004) Glycoprotein sialylation in plants? Nat Biotechnol 22:1351–1352CrossRefGoogle Scholar
  64. Seon JH, Szarka S, Moloney M (2002) A unique strategy for recovering recombinant proteins from molecular farming: affinity capture on engineered oilbodies. J Plant Biotechnol 4:95–101Google Scholar
  65. Shah MM, Fujiyama K, Flynn CR, Joshi L (2003) Presence of sialylated endogenous glyconju-gates in plant cells. Nat Biotechnol 21:1470–1471PubMedCrossRefGoogle Scholar
  66. Shields RL, Lai J, Keck, R, O'Connell, L.Y, Hong, K, Meng, Y.G, Weikert, S.H.A, Presta, L (2002) Lack of Fucose on human IgG1 N-linked Oligosaccharide improves binding to human FcgRIII and antibody-dependent cellular toxicity. J Biol Chem 277:26733–26740PubMedCrossRefGoogle Scholar
  67. Smith G, Walmsley A, Polkinghorne I (1997) Plant-derived immunocontraceptive vaccines. Reprod Fertil Dev 9:85–89PubMedCrossRefGoogle Scholar
  68. Song WY, Sohn EJ, Martinoia E, Lee YJ, Yang YY, Jasinski M, Forestier C, Hwang I, Lee Y (2003) Engineering tolerance and accumulation of lead and cadmium in transgenic plants. Nat Biotechnol 21:914–919PubMedCrossRefGoogle Scholar
  69. Stoger E, Sack M, Fischer R, Christou P (2002) Plantibodies: applications, advantages and bottlenecks. Curr Opin Biotechnol 13:161–166PubMedCrossRefGoogle Scholar
  70. Stoger E, Sack M, Nicholson L, Fischer R, Christou P (2005) Recent progress in plantibody technology. Curr Pharmaceut Des 11:2439–2457CrossRefGoogle Scholar
  71. Stoger E, Vaquero C, Torres E, Sack M, Nicholson L, Drossard J, Williams S, Keen D, Perrin Y, Christou P, Fischer R (2000) Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 42:583–590PubMedCrossRefGoogle Scholar
  72. Tachibana H, Shirahata S, Murakami H (1992) Generation of specificity-variant antibodies by alteration of carbohydrate in light chain of human monoclonal antibodies. Biochem Biophys Res Commun 189:625–632PubMedCrossRefGoogle Scholar
  73. Trkola A, Kuster H, Rusert P, Joos B, Fischer M, Leemann C, Manrique A, Huber M, Rehr M, Oxenius A, Weber R, Stiegler G, Vcelar B, Katinger H, Aceto L, Gunthard HF (2005) Delay of HIV-1 rebound after cessation of antiretoviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11:615–622PubMedCrossRefGoogle Scholar
  74. Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engineered glycoforms of an antineuro-blastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17:176–180PubMedCrossRefGoogle Scholar
  75. Vaccaro C, Zhou J, Ober RJ, Ward E.S (2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotechnol 23:1283–1288PubMedCrossRefGoogle Scholar
  76. Valdes R, Gomez L, Padilla S, Brito J, Reyes B, Alvarez T, Mendoza O, Herrera O, Ferro W, Pujol M, Leal V, Linares M, Hevia Y, Garcia C, Mila L, Garcia O, Sanchez R, Acosta A, Geada D, Paez R, Luis Vega J, Borroto C (2003) Large-scale purification of an antibody directed against hepatitis B surface antigen from transgenic tobacco plants. Biochem Biophys Res Commun 308:94–100PubMedCrossRefGoogle Scholar
  77. Vaquero C, Sack M, Schuster F, Finnern R, Drossard J, Schumann D, Reimann A, Fischer R (2002) A carcinoembryonic antigen-specific diabody produced in tobacco. FASEB J 16:408–410PubMedGoogle Scholar
  78. Verch T, Yusibov V, Koprowski H (1998) Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector. J Immunological Methods 220:69–75CrossRefGoogle Scholar
  79. Vietta ES, Uhr JW (1994) Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy. Cancer Res 54:5301–5309Google Scholar
  80. Voss A, Niersbach M, Hain R, Hirsch HJ, Liao YC, Kreuzaler F, Fischer R (1995) Reduced virus infectivity in N. tabacum secreting a TMV-specific full-size antibody. Molecular Breeding 1:39–50CrossRefGoogle Scholar
  81. Vrain TC (1999) Engineering natural and synthetic resistance for nematode management. J Nematol 31:424–436PubMedGoogle Scholar
  82. Vuist WM, Levy R, Maloney DG (1994) Lymphoma regression induced by monoclonal anti-idi-otypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein. Blood 83:899–906PubMedGoogle Scholar
  83. Weiner LM, Carter P (2005) Tunable antibodies. Nat Biotechnol 23:556–557PubMedCrossRefGoogle Scholar
  84. Wenderoth I, von Schaewen A (2000) Isolation and characterization of plant- N-acetyl glucosami-nyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant Physiol 123:1097–1108PubMedCrossRefGoogle Scholar
  85. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12:433–455PubMedCrossRefGoogle Scholar
  86. Wright A, Morrison SL (1998) Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol 160:3393–3402PubMedGoogle Scholar
  87. Wright A, Tao MH, Kabat EA, Morrison SL (1991) Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J 10:2717–2123PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • K. Ko
    • 1
  • R. Brodzik
    • Z. Steplewski
      1. 1.Department of Biologcal Science, College of Natural SciencesWonkwang UniversityIksanKorea

      Personalised recommendations